Japan And US: Secret Deal To Block Cancer Drugs?

WikiLeaks claims that patients needing drugs will be hit with hugely expensive bills.

Excerpts from a proposed international trade agreement, leaked to the web this week, suggest that the United States is pushing for changes that will make getting life-saving drugs overseas very difficult. 

WikiLeaks found that the U.S. is creating obstacles for affordable access to drugs like cancer medication with the Trans-Pacific Partnership (TPP). 

The TPP aims to reduce the ability of manufacturers to create more affordable drugs. Additionally, it increases pharmaceutical companies' ability to retain monopolies. Latin American and Asian countries, with the exception of Japan, oppose the proposals.

Julian Assange, the editor-in-chief of WikiLeaks, said in a statement that: “This clearly demonstrates that such an all-encompassing and divisive trade agreement is too damaging to be brought into force. The TPP should stop now.”

Transparency advocates, note that the TPP has been negotiated almost entirely in secrecy. 

“No wonder they kept it secret,” said online entrepreneur Kim Dotcom of New Zealand. “What a malicious piece of US corporate lobbying. TPP is about world domination for US corporations. Nothing else. We will stop this madness in New Zealand.”

A MoveOn.org petition has almost 9,000 signatures and urges all lawmakers to vote no on the TPP. 

"We urge all our Congressional representatives, Senators and Representatives, to vote no on fast track legislation for the Trans-Pacific Partnership (TPP). An agreement like the TPP should be negotiated in the full light of day. America must reserve the right to determine our own consumer, health, safety, labor, privacy and environmental regulations. Do not surrender our rights to Trans National Corporations."

View Comments

Recommended For You